Argenica Bids Farewell to Director Geoff Pocock

Argenica Therapeutics Ltd (AU:AGN) has released an update.

Argenica Therapeutics Limited has announced that Geoff Pocock has ceased to be a director of the company as of June 5, 2024. Following his departure, Pocock holds no registered securities but maintains an indirect interest in the company through 4,730,929 fully paid ordinary shares held by Oofy Prosser Pty Ltd. No further details or interests in contracts were disclosed in this final director’s interest notice.

For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.